New Search

Your search found 43 records, sorted by year and then date of acquisition.

1. A Randomized Placebo-Controlled Trial of N-acetylcysteine for Cannabis Use Disorder in Adults. doc type
  Gray, Kevin M. ; Sonne, Susan C. ; McClure, Erin A. ; Ghitza, Udi E. ; Matthews, Abigail G. ; McRae-Clark, Aimee L. ; Carroll, Kathleen M. ; Potter, Jennifer Sharpe ; Wiest, Katharina ; Mooney, Larissa J. ; Hasson, Albert ; Walsh, Sharon L. ; Lofwall, Michelle R. ; Babalonis, Shanna ; Lindblad, Robert W. ; Sparenborg, Steven ; Wahle, Aimee ; King, Jacqueline S. ; Baker, Nathaniel L. ; Tomko, Rachel L. ; Haynes, Louise F. ; Vandrey, Ryan G. ; Levin, Frances R.
 Drug and Alcohol Dependence 2017;177:249-257. [doi: 10.1016/j.drugalcdep.2017.04.020].
 
2. Changes in Quality of Life in Cocaine-Dependent Participants Provided Treatment with Buprenorphine+Naloxone Combined with Extended Release Naltrexone. doc type
  Shmueli-Blumberg, Dikla ; Carrizales, Fermin A. ; Kazanis, William H. ; Hillhouse, Maureen ; Matthews, Abigail ; Potter, Jennifer Sharpe
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Palm Springs, CA, June 11-16, 2016.
 
3. Treatment Outcomes in Opioid Dependent Patients with Different Buprenorphine/Naloxone Induction Dosing Patterns and Trajectories. doc type
  Jacobs, Petra ; Ang, Alfonso ; Hillhouse, Maureen P. ; Saxon, Andrew J. ; Nielsen, Suzanne ; Wakim, Paul G. ; Mai, Barbara E. ; Mooney, Larissa J. ; Potter, Jennifer Sharpe ; Blaine, Jack D.
 American Journal on Addictions 2015;24:667-675. [doi: 10.1111/ajad.12288].
 
4. Long-term Outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Griffin, Margaret L. ; Provost, Scott E. ; Fitzmaurice, Garrett M. ; McDermott, Katherine A. ; Srisarajivakul, Emily N. ; Dodd, Dorian R. ; Dreifuss, Jessica A. ; McHugh, R. Kathryn ; Carroll, Kathleen M.
 Drug and Alcohol Dependence 2015;150:112-119. [doi: 10.1016/j.drugalcdep.2015.02.030].
 
5. Opioid Withdrawal, Craving, and Use During and After Outpatient Buprenorphine Stabilization and Taper: A Discrete Survival and Growth Mixture Model. doc type
  Northrup, Thomas F. ; Stotts, Angela L. ; Green, Charles ; Potter, Jennifer Sharpe ; Marino, Elise N. ; Walker, N. Robrina ; Weiss, Roger D. ; Trivedi, Madhukar H.
 Addictive Behaviors 2015;41:20-28. [doi: 10.1016/j.addbeh.2014.09.021].
 
6. The Multi-Site Prescription Opioid Addiction Treatment Study: 18-Month Outcomes. doc type
  Potter, Jennifer Sharpe ; Dreifuss, Jessica A. ; Marino, Elise N. ; Provost, Scott E. ; Dodd, Dorian R. ; Rice, Lindsay S. ; Fitzmaurice, Garrett M. ; Griffin, Margaret L. ; Weiss, Roger D.
 Journal of Substance Abuse Treatment 2015;48(1):62-69. [doi: 10.1016/j.jsat.2014.07.009].
 
7. Who Benefits from Additional Drug Counseling Among Prescription Opioid Dependent Patients Receiving Buprenorphine-Naloxone and Standard Medical Management? doc type
  Weiss, Roger D. ; Griffin, Margaret L. ; Potter, Jennifer Sharpe ; Dodd, Dorian R. ; Dreifuss, Jessica A. ; Connery, Hilary Smith ; Carroll, Kathleen M.
 Drug and Alcohol Dependence 2014;104(1):118-122. [doi: 10.1016/j.drugalcdep.2014.04.005].
 
8. Reasons for Opioid Use Among Patients with Dependence on Prescription Opioids: The Role of Chronic Pain. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Griffin, Margaret L. ; McHugh, R. Kathryn ; Haller, Deborah L. ; Jacobs, Petra ; Gardin, John G. II ; Fischer, Daniel ; Rosen, Kristen D.
 Journal of Substance Abuse Treatment 2014;47(2):140-145. [doi: 10.1016/j.jsat.2014.03.004].
 
9. Baseline Characteristics and Treatment Outcomes in Prescription Opioid Dependent Patients With and Without Co-Occurring Psychiatric Disorder. doc type
  Griffin, Margaret L. ; Dodd, Dorian R. ; Potter, Jennifer Sharpe ; Rice, Lindsay S. ; Dickinson, William ; Sparenborg, Steven ; Weiss, Roger D.
 American Journal of Drug and Alcohol Abuse 2014;40(2):157-162. [doi: 10.3109/00952990.2013.842241].
 
10. The Relationship Between Primary Prescription Opioid and Buprenorphine-Naloxone Induction Outcomes in a Prescription Opioid Dependent Sample. doc type
  Nielsen, Suzanne ; Hillhouse, Maureen ; Weiss, Roger D. ; Mooney, Larissa ; Potter, Jennifer Sharpe ; Lee, Joshua ; Gourevitch, Marc N. ; Ling, Walter
 American Journal on Addictions 2014;23(4):343-348. [doi: 10.1111/j.1521-0391.2013.12105.x].
 
11. Concurrent Substance Abuse is Associated with Sexual Risk Behavior Among Adults Seeking Treatment for Prescription Opioid Dependence. doc type
  Meade, Christina S. ; Bevilacqua, Lisa A. ; Moore, Elizabeth D. ; Griffin, Margaret L. ; Gardin, John G. II ; Potter, Jennifer Sharpe ; Hatch-Maillette, Mary A. ; Weiss, Roger D.
 American Journal on Addictions 2014;23(1):27-33. [doi: 10.1111/j.1521-0391.2013.12057.x].
 
12. CTN Webinar: Adaptive Research Design for Substance Abuse Clinical Trials. doc type
  Wiest, Katharina ; Potter, Jennifer Sharpe
 Produced by the National Drug Abuse Treatment Clinical Trials Network's Clinical Coordinating Center, October 23, 2013.
 
13. Opioid Withdrawal and Craving Trajectories Following Buprenorphine Taper: A Latent Class and Growth Mixture Model of Time-to-First Opioid Lapse. doc type
  Northrup, Thomas F. ; Stotts, Angela L. ; Green, Charles ; Potter, Jennifer Sharpe ; Marino, Elise N. ; Weiss, Roger D. ; Mulpur, Swetha ; Walker, N. Robrina ; Trivedi, Madhukar H.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Diego, CA, June 15-20, 2013.
 
14. Buprenorphine/Naloxone and Methadone Maintenance Treatment Outcomes for Opioid Analgesic, Heroin, and Combined Users: Findings from Starting Treatment with Agonist Replacement Therapies (START). doc type
  Potter, Jennifer Sharpe ; Marino, Elise N. ; Hillhouse, Maureen P. ; Nielsen, Suzanne ; Wiest, Katharina ; Canamar, Catherine P. ; Martin, Judith A. ; Ang, Alfonso ; Baker, Rachel ; Saxon, Andrew J. ; Ling, Walter
 Journal of Studies on Alcohol and Drugs 2013;74(4):605-613..
 
15. Racial/Ethnic Differences in the Rates and Correlates of HIV Risk Behaviors Among Drug Abusers. doc type
  Brooks, Audrey J. ; Lokhnygina, Yuliya ; Meade, Christina S. ; Potter, Jennifer Sharpe ; Calsyn, Donald A. ; Greenfield, Shelly F.
 American Journal on Addictions 2013;22(2):136-147. [doi: 10.1111/j.1521-0391.2013.00303.x].
 
16. Patient Characteristics Associated with Buprenorphine/Naloxone Treatment Outcome for Prescription Opioid Dependence: Results from a Multisite Study. doc type
  Dreifuss, Jessica A. ; Griffin, Margaret L. ; Frost, Katherine ; Fitzmaurice, Garrett M. ; Potter, Jennifer Sharpe ; Fiellin, David A. ; Selzer, Jeffrey A. ; Hatch-Maillette, Mary A. ; Sonne, Susan C. ; Weiss, Roger D.
 Drug and Alcohol Dependence 2013;131(1-2):112-118. [doi: 10.1016/j.drugalcdep.2012.12.010].
 
17. Gender Differences in a Clinical Trial for Prescription Opioid Dependence. doc type
  McHugh, R. Kathryn ; DeVito, Elise E. ; Dodd, Dorian ; Carroll, Kathleen M. ; Potter, Jennifer Sharpe ; Greenfield, Shelly F. ; Connery, Hilary Smith ; Weiss, Roger D.
 Journal of Substance Abuse Treatment 2013;45(1):38-43. [doi: 10.1016/j.jsat.2012.12.007].
 
18. CTN Webinar: Helping Patients with Substance Use Disorders and Pain. doc type
  Potter, Jennifer Sharpe ; Weiss, Roger D.
 Produced by the National Drug Abuse Treatment Clinical Trials Network's Clinical Coordinating Center, December 19, 2012.
 
19. Predictors of Attrition with Buprenorphine/Naloxone Treatment in Opioid Dependent Youth. doc type
  Warden, Diane ; Subramaniam, Geetha A. ; Carmody, Thomas ; Woody, George E. ; Minhajuddin, Abu T. ; Poole, Sabrina A. ; Potter, Jennifer Sharpe ; Fishman, Marc J. ; Bogenschutz, Michael P. ; Patkar, Ashwin A. ; Trivedi, Madhukar H.
 Addictive Behaviors 2012;37(9):1046-1053. [doi: 10.1016/j.addbeh.2012.04.011].
 
20. 2012 Texas Research to Practice Conference: Learn how Science is Impacting Addiction Treatment. doc type doc type doc type
  Trivedi, Madhukar H. ; Crowell, A. Rebecca ; Denton, Douglas ; Kosten, Thomas ; Potter, Jennifer Sharpe ; Hien, Denise A. ; Spence, Richard ; Levy, Michael S. ; Muir, Joan A.
 Dissemination Conference sponsored by the Texas Node, Dallas, TX, April 30, 2012.
 
21. Advances in Clinical Research for Prescription Opioid Dependence. doc type
  Provost, Scott E. ; Potter, Jennifer Sharpe ; Weiss, Roger D.
 Presented at the National Association of Social Workers Massachusetts Chapter Symposium, Framingham, MA, March 29-30, 2012.
 
22. CTN Webinar: Site Selection Strategies in Substance Abuse Research. doc type
  Potter, Jennifer Sharpe ; Rothwell, Ro Shauna
 Produced by the National Drug Abuse Treatment Clinical Trials Network's Clinical Coordinating Center, February 8, 2012.
 
23. Randomized Multi-site Trial of the Job Seekers' Workshop in Patients with Substance Use Disorders. doc type doc type
  Svikis, Dace S. ; Keyser-Marcus, Lori ; Stitzer, Maxine L. ; Rieckmann, Traci R. ; Safford, Lauretta ; Loeb, Peter ; Allen, Tim ; Luna-Anderson, Carol ; Back, Sudie E. ; Cohen, Judith ; DeBernardi, Michael A. ; Dillard, Bruce ; Forcehimes, Alyssa A. ; Jaffee, William B. ; Killeen, Therese ; Kolodner, Ken B. ; Levy, Michael S. ; Pallas, Diane ; Perl, Harold I. ; Potter, Jennifer Sharpe ; Provost, Scott E. ; Reese, Karen ; Sampson, Royce ; Sepulveda, Allison ; Snead, Ned ; Wong, Conrad J. ; Zweben, Joan E.
 Drug and Alcohol Dependence 2012;120(1-3):55-64. [doi: 10.1016/j.drugalcdep.2011.06.024].
 
24. Predictors of Abstinence: National Institute of Drug Abuse Multisite Buprenorphine/Naloxone Treatment Trial in Opioid-Dependent Youth. doc type
  Subramaniam, Geetha A. ; Warden, Diane ; Minhajuddin, Abu T. ; Fishman, Marc J. ; Stitzer, Maxine L. ; Adinoff, Bryon H. ; Trivedi, Madhukar H. ; Weiss, Roger D. ; Potter, Jennifer Sharpe ; Poole, Sabrina A. ; Woody, George E.
 Journal of the American Academy of Child & Adolescent Psychiatry 2011;50(11):1120-1128. [doi: 10.1016/j.jaac.2011.07.010].
 
25. Adjunctive Counseling During Brief and Extended Buprenorphine-Naloxone Treatment for Prescription Opioid Dependence: A 2-Phase Randomized Controlled Trial. doc type doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Fiellin, David A. ; Byrne, Mimmie ; Connery, Hilary Smith ; Dickinson, William ; Gardin, John G. II ; Griffin, Margaret L. ; Gourevitch, Marc N. ; Haller, Deborah L. ; Hasson, Albert L. ; Huang, Zhen ; Jacobs, Petra ; Kosinski, Andrzej S. ; Lindblad, Robert ; McCance-Katz, Elinore F. ; Provost, Scott E. ; Selzer, Jeffrey A. ; Somoza, Eugene C. ; Sonne, Susan C. ; Ling, Walter
 Archives of General Psychiatry 2011;68(12):1238-1246. [doi: 10.1001/archgenpsychiatry.2011.121].
 
26. Site Selection in Community-Based Clinical Trials for Substance Use Disorders: Strategies for Effective Site Selection. doc type
  Potter, Jennifer Sharpe ; Donovan, Dennis M. ; Weiss, Roger D. ; Gardin, John G. II ; Lindblad, Robert ; Wakim, Paul G. ; Dodd, Dorian R.
 American Journal of Drug and Alcohol Abuse 2011;37(5):400-407. [doi: 10.3109/00952990.2011.596975].
 
27. Determining the Primary Endpoint for a Stimulant Abuse Trial: Lessons Learned from STRIDE (CTN 0037). doc type
  Trivedi, Madhukar H. ; Greer, Tracy L. ; Potter, Jennifer Sharpe ; Grannemann, Bruce D. ; Nunes, Edward V. ; Rethorst, Chad ; Warden, Diane ; Ring, Kolette M. ; Somoza, Eugene C.
 American Journal of Drug and Alcohol Abuse 2011;37(5):339-349. [doi: 10.3109/00952990.2011.598589].
 
28. Predictors of Outcome in the Multi-Site CTN Prescription Opioid Addiction Treatment Study. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Griffin, Margaret L. ; Connery, Hilary Smith ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Hollywood, FL, June 18-23, 2011.
 
29. A Community-Based, Two-Phase Randomized Controlled Trial of Buprenorphine With and Without Individual Drug Counseling for the Treatment of Opioid Analgesic Addiction. doc type
  Provost, Scott E. ; Potter, Jennifer Sharpe ; Weiss, Roger D. ; Jacobs, Petra ; Ling, Walter
 Poster presented at the American Public Health Association (APHA) Annual Meeting, Denver, CO, November 6-10, 2010..
 
30. Alterations in Brain Structure and Functional Connectivity in Prescription Opioid-Dependent Patients. doc type
  Upadhyay, Jaymin ; Maleki, Nasim ; Potter, Jennifer Sharpe ; Elman, Igor ; Rudrauf, David ; Knudsen, Jaime ; Wallin, Diane ; Pendse, Gautam ; McDonald, Leah ; Griffin, Margaret L. ; Anderson, Julie ; Nutile, Lauren ; Renshaw, Perry ; Weiss, Roger D. ; Becerra, Lino ; Borsook, David
 Brain 2010;133(7):2098-2114. [doi: 10.1093/brain/awq138].
 
31. Gender Differences in the Rates and and Correlates of HIV Risk Behaviors Among Drug Abusers. doc type
  Brooks, Audrey J. ; Meade, Christina S. ; Potter, Jennifer Sharpe ; Lokhnygina, Yuliya ; Calsyn, Donald A. ; Greenfield, Shelly F.
 Substance Use & Misuse 2010;45(14):2444-2469. [doi: 10.3109/10826084.2010.490928].
 
32. Pain and Continued Opioid Use in Individuals Receiving Buprenorphine-Naloxone for Opioid Detoxification: Secondary Analyes from the Clinical Trials Network. doc type
  Potter, Jennifer Sharpe ; Chakrabarti, Amit ; Domier, Catherine P. ; Hillhouse, Maureen P. ; Weiss, Roger D. ; Ling, Walter
 Journal of Substance Abuse Treatment 2010;38(suppl 1):S80-S86. [doi: 10.1016/j.jsat.2009.12.007].
 
33. A Method to Diagnose Opioid Dependence Resulting from Heroin Versus Prescription Opioids Using the Composite International Diagnostic Interview. doc type
  Potter, Jennifer Sharpe ; Prather, Kristi ; Kropp, Frankie B. ; Byrne, Mimmie ; Sullivan, Carl Rollynn ; Mohamedi, Nadia ; Copersino, Marc L. ; Weiss, Roger D.
 Contemporary Clinical Trials 2010;31(2):185-188. [doi: 10.1016/j.cct.2010.01.002].
 
34. Conducting Clinical Research with Prescription Opioid Dependence: Defining the Population. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Copersino, Marc L. ; Prather, Kristi ; Jacobs, Petra ; Provost, Scott E. ; Chim, David ; Selzer, Jeffrey A. ; Ling, Walter
 American Journal on Addictions 2010;19(2):141-146. [doi: 10.1111/j.1521-0391.2009.00017.x].
 
35. A Multi-Site, Two-Phase, Prescription Opioid Addiction Treatment Study (POATS): Rationale, Design, and Methodology. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Provost, Scott E. ; Huang, Zhen ; Jacobs, Petra ; Hasson, Albert L. ; Lindblad, Robert ; Connery, Hilary Smith ; Prather, Kristi ; Ling, Walter
 Contemporary Clinical Trials 2010;31(2):189-199. [doi: 10.1016/j.cct.2010.01.003].
 
36. Gender Differences in Rates and Correlates of HIV Risk Behaviors Among Drug Dependent Individuals. doc type
  CTN Gender Special Interest Group ; Brooks, Audrey J. ; Meade, Christina S. ; Potter, Jennifer Sharpe ; Lokhnygina, Yuliya ; Calsyn, Donald A. ; Greenfield, Shelly F.
 Presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Reno/Sparks, Nevada, June 20-25, 2009.
 
37. Use of an Adaptive Treatment Research Design in a CTN Study of Prescription Opioid Dependence Treatment. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Byrne, Mimmie ; Sullivan, Carl Rollynn ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Reno/Sparks, Nevada, June 20-25, 2009.
 
38. Extended vs. Short-Term Buprenorphine-Naloxone for Treatment of Opioid-Addicted Youth: A Randomized Trial. doc type doc type
  Woody, George E. ; Poole, Sabrina A. ; Subramaniam, Geetha A. ; Dugosh, Karen L. ; Bogenschutz, Michael P. ; Abbott, Patrick J. ; Patkar, Ashwin A. ; Publicker, Mark ; McCain, Karen ; Potter, Jennifer Sharpe ; Forman, Robert F. ; Vetter, Victoria ; McNicholas, Laura F. ; Blaine, Jack D. ; Lynch, Kevin G. ; Fudala, Paul
 JAMA 2008;300(17):2003-2011. [doi: 10.1001/jama.2008.574].
 
39. CTN Webinar: Good Clinical Practice. doc type
  Potter, Jennifer Sharpe
 Produced by the National Drug Abuse Treatment Clinical Trials Network's Clinical Coordinating Center, October 14, 2008.
 
40. CTN Webinar: Informed Consent for Human Participant Research. doc type
  Kunkel, Lynn E. ; Potter, Jennifer Sharpe
 Produced by the National Drug Abuse Treatment Clinical Trials Network's Clinical Coordinating Center, July 24, 2008.
 
41. CTN Webinar: Recruitment and Retention. doc type
  Kunkel, Lynn E. ; Potter, Jennifer Sharpe
 Produced by the National Drug Abuse Treatment Clinical Trials Network's Clinical Coordinating Center, June 18, 2008.
 
42. A Feasibility Study of a Web-Based Performance Improvement System for Substance Abuse Treatment Providers. doc type doc type
  Forman, Robert F. ; Crits-Christoph, Paul ; Kaynak, Ovgu ; Worley, Matt ; Hantula, Donald A. ; Kulaga, Agatha ; Rotrosen, John ; Chu, Melissa ; Gallop, Robert ; Potter, Jennifer Sharpe ; Muchowski, Patrice ; Brower, Kirk ; Strobbe, Stephen ; Magruder, Kathryn M. ; Chellis, A'Delle H. ; Clodfelter, Tad ; Cawley, Margaret
 Journal of Substance Abuse Treatment 2007;33(4):363-371. [doi: 10.1016/j.jsat.2007.01.007].
 
43. Patient Feedback Manual, Version 1.0 doc type
  Forman, Robert F. ; Krejci, Jonathan ; Selzer, Jeffrey A. ; Hantula, Donald A. ; Potter, Jennifer Sharpe ; Brower, Kirk ; Grissom, Grant ; Arfken, Cynthia L. ; Scruton, Theresa
 Philadelphia, PA: University of Pennsylvania, Treatment Research Institute, 2003.
 

New Search